PlainPharmaWatch

CMS Open Payments · Program Year 2024

Barco, Inc.

Barco, Inc. reported $175,278.11 across General Payments, Research, and Ownership to 66 physicians and teaching hospitals across 66 transactions.

$175.3K
All-tracks total
66
Transactions
66
Recipients
+$5.9K
General Payments vs PY2023

Barco, Inc. reported $175,278.11 across all CMS Open Payments tracks (General + Research + Ownership) to 66 physicians and teaching hospitals in Program Year 2024 - ranking #1045 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $175,278.11, averaging $2.7K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer barco-inc Barco, Inc.

$175.3K · #1045/1,925 · 0.0% industry · PY2024

  • TOT $175.3K
  • RANK #1045
  • SHARE 0.0%
  • TXN 66
  • RCP 66
  • CAT 2
  • GEN $175.3K
  • ΔGEN +$5.9K
  • TOP1 13.5%
  • PY 2024

Nearest volume peer: GS Solutions, Inc. ($175.2K)

Dmg America LLC$176.1KCarestream Dental, LLC$175.9KVisionCare Inc.$175.6KBarco, Inc. (this)$175.3KGS Solutions, Inc.$175.2K
All-tracks payment totals near Barco, Inc. (CMS Open Payments PY2024)

Barco, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Barco, Inc.'s CMS-reported General Payments increased by $5.9K (+3.5%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: BARCO, INC.PY2023: BARCO, INC.PY2024: Barco, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$169.4KPY2024$175.3K
PY2023
$169,391.51
PY2024
$175,278.11

What the Data Shows for Barco, Inc.

Rank #1045 of 1,925 companies in CMS Open Payments for 2024 belongs to Barco, Inc., which reported $175,278.11 across 66 transactions to 66 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $2.7K per transaction and $2.7K per recipient.

The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Long-Term Medical Supply or Device Loan" at $171.6K, accounting for 97.9% of this company's General Payments and 29 transactions.

General Payment Breakdown by Type

Across 2 types of general payments, Barco, Inc.'s largest category was "Long-Term Medical Supply or Device Loan" at $171.6K - 97.9% of General Payments.

How Barco, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Long-Term Medical Supply …$171.6K2. Food and Beverage$3.7K
Payment Type Amount Transactions
Long-Term Medical Supply or Device Loan $171.6K 29
Food and Beverage $3.7K 37

Recipient Concentration in General Payments

The five largest recipient relationships account for $91,003.55 (51.9%) of $175,278.11 in this company's General Payments records across 33 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Barco, Inc.

The five named recipients with the highest reported General Payments from this company

Nyu Langone Hospitals$23.7KLoma Linda University Medica…$19.0KCleveland Clinic Hospital$19.0KLac Olive View/Ucla Medical …$19.0KSanford Bismarck$10.3K
  1. 1

    Nyu Langone Hospitals

    $23,714.53 across 4 reported transactions

  2. 2

    Loma Linda University Medical Center

    $18,999.99 across 1 reported transactions

  3. 3

    Cleveland Clinic Hospital

    $18,999.99 across 1 reported transactions

  4. 4

    Lac Olive View/Ucla Medical Center

    $18,999.00 across 1 reported transactions

  5. 5

    Sanford Bismarck

    $10,290.04 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Barco, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Barco, Inc..

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Barco, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Barco, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.